利爾化學(002258)優質農藥成長企業迎來基本面拐點 | 集結令68期

作者 | 格隆彙集結令
數據支持 | 勾股大數據

目前草銨膦成交價已有16萬,未來草銨膦價格中樞依然有望持續好於市場預期。同時利爾化學廣安基地新工藝併線進程漸行漸近,三季度在量上能超預期嗎?
利爾化學股份有限公司由中國工程物理研究院於1993年發起設立,於2008年7月在深交所掛牌上市。公司總部位於四川省綿陽市,擁有四川綿陽、江蘇南通、四川廣安、湖南嶽陽、河南鶴壁五個生產基地,員工3000多人。公司主要從事高效、安全類農藥的研發、生產和銷售,產品包括除草劑、殺蟲劑、殺菌劑三大系列共30餘個原藥、100餘個製劑品種以及部分化工中間體。產品出口美國、巴西、阿根廷、澳大利亞等三十多個國家和地區,與美國陶氏。

會議時間:2020/8/6 16:30-17:30
會議主題:利爾化學(002258)優質農藥成長企業迎來基本面拐點
會議主講:陳煜(浙商化工首席分析師)
參會資格:對格隆匯至尊會員與機構會員免費開放,諮詢客服獲取限量免費參會資格。
參會方式:掃碼聯繫格隆匯-機構客服(微信ID:glh-jg),或者對口銷售經理。

掃碼添加客服報名參會
“格隆彙集結令”近期還有以下主題沙龍,讓更多投資者深入瞭解不同行業,分析市場,把握投資機會。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.